NCT05466071View on ClinicalTrials.gov

Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Chronic Hepatitis bPregnancy Related
Trial Locations (1)

510150

RECRUITING

The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Xingfei Pan

OTHER